Institute of Clinical Physiology, National Research Council, Pisa Italy.
Curr Pharm Des. 2011;17(28):3074-80. doi: 10.2174/138161211798157720.
Obesity, insulin resistance, glucose intolerance/type 2 diabetes and hypertension are clustered in the metabolic syndrome representing critical risk factors for increased incidence cardio-cerebro-vascular diseases, kidney failure and cancer. Ectopic fat accumulation, i.e., accumulation in the mediastinum, liver and the abdomen, as well as generalized fat accumulation are associated with arterial hypertension, either systolic or diastolic. Several mechanisms including insulin resistance, sub-inflammatory state, increased Renin- Angiotensin-Aldosterone System (RAAS) system activity, oxidative stress, autonomic dysregulation as well as mechanical compression on the kidneys are all activated by obesity. Interestingly angiotensin-converting enzyme (ACE) inhibitors and angiotensin II (ATII) receptor blockers, while correcting arterial hypertension, also have a positive effect on glucose metabolism and diabetes prevention, in high risk patients. The implementation of dietary, medical and surgical strategies to prevent and treat obesity, are cornerstones for the primary prevention as well as treatment of arterial hypertension.
肥胖、胰岛素抵抗、葡萄糖耐量异常/2 型糖尿病和高血压在代谢综合征中聚集,代表了心血管疾病、肾衰竭和癌症发病率增加的关键危险因素。异位脂肪堆积,即纵隔、肝脏和腹部的脂肪堆积,以及全身性脂肪堆积,与动脉高血压(收缩压或舒张压)有关。包括胰岛素抵抗、亚炎症状态、肾素-血管紧张素-醛固酮系统(RAAS)活性增加、氧化应激、自主神经失调以及对肾脏的机械压迫在内的多种机制,都会被肥胖所激活。有趣的是,血管紧张素转换酶(ACE)抑制剂和血管紧张素 II(ATII)受体阻滞剂在纠正动脉高血压的同时,对高风险患者的葡萄糖代谢和糖尿病预防也有积极作用。实施饮食、医疗和手术策略来预防和治疗肥胖,是预防和治疗动脉高血压的基石。